| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 85 |
| 1 | ADALIMUMAB-AATY | 67 |
| 2 | ADALIMUMAB-ADAZ | 67 |
| 3 | ADALIMUMAB-FKJP | 67 |
| 4 | METHOTREXATE SODIUM | 38 |
| 5 | INFLIXIMAB | 31 |
| 6 | METHOTREXATE | 27 |
| 7 | ETANERCEPT | 20 |
| 8 | USTEKINUMAB | 19 |
| 9 | CANAKINUMAB | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADALIMUMAB-FKJP | 67 | 0.0015 |
| 1 | ADALIMUMAB-AATY | 67 | 0.0014 |
| 2 | ADALIMUMAB-ADAZ | 67 | 0.0012 |
| 3 | OMADACYCLINE | 2 | 0.0012 |
| 4 | ALGLUCOSIDASE ALFA | 2 | 0.0008 |
| 5 | CANAKINUMAB | 8 | 0.0007 |
| 6 | CEFOTAXIME INJECTION | 2 | 0.0005 |
| 7 | GOLIMUMAB | 4 | 0.0003 |
| 8 | CLOFAZIMINE | 2 | 0.0003 |
| 9 | USTEKINUMAB | 19 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 2 | 0.0006 |
| 2 | Tetracycline-class Antibacterial [EPC] | 2 | 0.0003 |
| 3 | Interleukin-23 Antagonist [EPC] | 20 | 0.0002 |
| 4 | Interleukin-12 Antagonist [EPC] | 19 | 0.0002 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 83 | 0.0001 |
| 6 | Antimycobacterial [EPC] | 2 | 0.0001 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 27 | 0.0001 |
| 8 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 9 | Interleukin-17A Antagonist [EPC] | 2 | 0.0001 |